Shaanxi Kanghui Pharmaceutical (603139.SH) announced that on August 1, 2024, T, a shareholder holding more than 5% of the company's shares, will...
Zhixing Finance APP News, Kanghui Pharmaceutical (603139.SH) announced that on August 1, 2024, TBP, a shareholder holding more than 5% of the company's shares, signed a "Share Transfer Agreement" with Shanghai Salexian Enterprise Management Consulting Co., Ltd. ("Salexian") to transfer 9.988 million unrestricted circulating shares of the company (10% of the total share capital of the company) held by TBP to Salexian, at a transfer price of 11.08 yuan/share and a transfer total price of 1.11 billion yuan. This equity change will not cause a change in the controlling shareholder or actual controller of the company.
Before the equity change, TBP held 14.7921 million shares of the company, accounting for 14.8099% of the total share capital of the company. After the equity change, TBP holds 4.8041 million shares of the company, accounting for 4.8099% of the total share capital of the company. Before the equity change, Salexian did not hold any shares of the company. After the equity change, Salexian holds 9.988 million shares of the company, accounting for 10% of the total share capital of the company, and becomes a shareholder holding more than 5% of the company's shares.
